Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Cash Flows from Operating activities:
Net (loss) income	$ (35,944)	$ 13,790
Adjustments to reconcile net (loss) income to net cash used in operating activities:
Depreciation and amortization	917	820
Reserve for inventory obsolescence	3,879	796
Change in fair value of preferred stock warrant and contingent shares liability	(152)	143
Change in fair value of derivative liability		(12,247)
Deferred tax benefit		(12)
Non-cash interest expense	6,705	3,237
Stock-based compensation	5,994	2,137
Allowance for credit losses	(1,616)	1,968
Loss on debt extinguishment		171
Non-cash lease expense	820	710
Accretion of interest on marketable securities	(260)	(333)
Loss on disposal of property and equipment		16
Changes in operating assets and liabilities:
Accounts receivable	(350)	(6,393)
Inventory	10,733	(33,318)
Prepaid expenses and other assets	1,598	1,183
Accounts payable	(3,387)	(4,115)
Accrued expenses and other liabilities	(2,011)	1,975
Deferred revenue	429	(666)
Warranty liability	75	1,456
Operating lease liabilities	(837)	(697)
Net cash used in operating activities	(13,407)	(29,379)
Investing activities:
Purchase of marketable securities	(6,756)	(53,483)
Acquisition of fSight		(16)
Purchase of intangible assets		(450)
Purchase of property and equipment	(757)	(1,855)
Sales and maturities of marketable securities	25,818	14,885
Net cash provided by (used in) investing activities	18,305	(40,919)
Financing activities:
Proceeds from Convertible Promissory Note		50,000
Repayment of from Series 2022-1 Notes		(20,833)
Payment of financing costs		(358)
Proceeds from Business Combination		2,238
Proceeds from exercise of stock options	272	212
Payment of tax withholdings on equity instruments	(114)	(91)
Proceeds from common stock warrant redemption, net of issuance costs and payments to warrant holders of non-redeemed warrants		3,653
Net cash provided by financing activities	158	34,821
Net increase (decrease) in cash and cash equivalents	5,056	(35,477)
Cash and cash equivalents at beginning of period	4,405	37,717
Cash and cash equivalents at end of period	9,461	2,240
Supplemental disclosure of cash flow information:
Cash paid for interest	2,500	168
Cash paid for taxes	547	48
Supplemental schedule of non-cash investing and financing activities:
Operating lease right of use assets obtained in exchange for operating lease liabilities	159	2,187
Property and equipment in accounts payable	39	38
Non-cash consideration paid for the acquisition of fSight	375	10,974
Contingent shares liability from fSight acquisition		2,167
Unrealized gain (loss) resulting from change in fair value of marketable securities	$ 62	(156)
Net assets acquired from Roth CH Acquisition IV Co.		573
Fair value of derivative note liability at issuance		23,525
Convertible preferred stock dividends (Note 3)		12,581
Reclassification of deferred issuance costs to additional paid in capital		2,221
Conversion of convertible preferred stock into common stock in connection with the Business Combination (Note 3)		87,140
Issuance of preferred stock upon exercise of preferred warrants		2,008
Reclassification of convertible note derivative liability to equity		$ 11,278